About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
How I Treat the Ph-positive ALL Patient
By
Elias Jabbour
39 Videos
118 views
July 3, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
14:41
Sanofi
Efficacy and Safety of a Treatment Option for Adults with Multiple M…
Feat.
J. Mikhael
Featured Video
18:47
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations in R/R CLL - A Patient Case Study
Feat.
J. N. Allan
Related Content
AUTOPLAY
ON
22:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…
Feat.
T. Badar
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
50:34
Scripps MD Anderson Cancer Center
The Cure of Leukemias in the Next Decade: An Optimist’s View
Feat.
H. Kantarjian
04:02
Michael Burke
Updated Results from the BLAST and TOWER Studies: Safety and Efficac…
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
28:07
Indy Hematology Review
Controversies and Recommendations for the Treatment of ALL and Lymph…
Feat.
W. Stock
06:49
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Mini-Hyper-CVD Plus Venetoclax for Older Ad…
Feat.
M. Luskin
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Immunotherapies in Acute Leukemias: 2024 Update
Feat.
C. Lai
04:11
Total Health
ASCO 2022 Updates in Leukemia and MDS
Feat.
D. Sallman
11:02
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Asciminib Combined With Dasatinib and Predn…
Feat.
M. Luskin
17:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Chronic GVHD: A Case-Based Discussion
Feat.
L. Perry
42:06
UNC Lineberger Comprehensive Cancer Center
Let’s Take a BiTE Out of CRS and Neurotoxicity
Feat.
B. Kikani
04:45
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "The Impact of Inotuzumab Ozogamicin Treatme…
Feat.
I. Aldoss
28:57
Total Health
Highlights From Key Hematology Trials at ASCO® 2023
Feat.
J. Strauss
48:05
Yale Cancer Center
ALL - Progress in Research and Therapy in 2022
Feat.
H. Kantarjian
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
17:38
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Curative Potential of CAR T-Cell Therapy for ALL
Feat.
S. Grupp
11:18
Talha Badar
Targeting CD38 in Acute Leukemias: Current Data and Ongoing Clinical…
03:03
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Olverembatinib (HQP1351) Overcoming Ponatin…
Feat.
E. Jabbour